Cargando…
Vaccine trial hat-trick
Moderna's vaccine trial is the third in a week to release positive results, raising hopes for a choice of vaccines, reports Michael Le Page
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by New Scientist Limited.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832933/ https://www.ncbi.nlm.nih.gov/pubmed/33518970 http://dx.doi.org/10.1016/S0262-4079(20)32023-6 |
| _version_ | 1783641945976864768 |
|---|---|
| author | Page, Michael Le |
| author_facet | Page, Michael Le |
| author_sort | Page, Michael Le |
| collection | PubMed |
| description | Moderna's vaccine trial is the third in a week to release positive results, raising hopes for a choice of vaccines, reports Michael Le Page |
| format | Online Article Text |
| id | pubmed-7832933 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by New Scientist Limited. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78329332021-01-26 Vaccine trial hat-trick Page, Michael Le New Sci News & Technology Moderna's vaccine trial is the third in a week to release positive results, raising hopes for a choice of vaccines, reports Michael Le Page Published by New Scientist Limited. 2020-11-21 2020-11-20 /pmc/articles/PMC7832933/ /pubmed/33518970 http://dx.doi.org/10.1016/S0262-4079(20)32023-6 Text en © 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | News & Technology Page, Michael Le Vaccine trial hat-trick |
| title | Vaccine trial hat-trick |
| title_full | Vaccine trial hat-trick |
| title_fullStr | Vaccine trial hat-trick |
| title_full_unstemmed | Vaccine trial hat-trick |
| title_short | Vaccine trial hat-trick |
| title_sort | vaccine trial hat-trick |
| topic | News & Technology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832933/ https://www.ncbi.nlm.nih.gov/pubmed/33518970 http://dx.doi.org/10.1016/S0262-4079(20)32023-6 |
| work_keys_str_mv | AT pagemichaelle vaccinetrialhattrick |